Supplemental Table 2 from A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
Michael A. Postow,Susan J. Knox,Debra A. Goldman,Yuval Elhanati,Vikram Mavinkurve,Phillip Wong,Darragh Halpenny,Sunil K. Reddy,Kenya Vado,Danielle McCabe,Kristen Aufiero Ramirez,Mary Macri,Paul Schwarzenberger,Toni Ricciardi,Aileen Ryan,Ralph Venhaus,Parisa Momtaz,Alexander N. Shoushtari,Margaret K. Callahan,Paul B. Chapman,Jedd D. Wolchok,Priyanka B. Subrahmanyam,Holden T. Maecker,Katherine S. Panageas,Christopher A. Barker crossref（2023）
摘要
Per patient description of site of RT, response in irradiated volume, and baseline sum of target irradiated volume
查看译文
AI 理解论文
溯源树
样例
